Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2008
10/30/2008WO2008130600A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase
10/30/2008WO2008130322A1 Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
10/30/2008WO2008130321A2 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
10/30/2008WO2008130320A2 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
10/30/2008WO2008130319A2 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
10/30/2008WO2008130313A1 Imidazole derivatives as modulators of the gaba receptor for the treatment of gastrointestinal disorders
10/30/2008WO2008130021A2 Heterocyclic hydrazide compound and pesticidal use of the same
10/30/2008WO2008129380A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
10/30/2008WO2008129080A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
10/30/2008WO2008128987A1 Novel inhibitors
10/30/2008WO2008128985A1 Thiourea derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128983A1 Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128981A1 Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
10/30/2008WO2008128891A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008WO2008128647A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008WO2008128622A2 Pyridine compounds for liquid-crystalline mixtures
10/30/2008WO2008074752A3 Indolylmaleimide derivatives as kinase inhibitors
10/30/2008WO2008005542A3 Antiviral phosphinate compounds
10/30/2008US20080269505 Processes for preparing darifenacin hydrobromide
10/30/2008US20080269504 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
10/30/2008US20080269503 Processes for preparing darifenacin hydrobromide
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269270 Triol form of rosuvastatin and synthesis of rosuvastatin
10/30/2008US20080269262 Therameutin Modulators
10/30/2008US20080269255 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
10/30/2008US20080269250 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists
10/30/2008US20080269245 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269225 Prokineticin 1 receptor antagonists
10/30/2008US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080269211 Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders
10/30/2008US20080269207 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
10/30/2008US20080269200 Antiinflammatory agents; tissue repair; rheumatic disorders; asthma; chronic onstructive pulmonary disease; osteoporosis; psoriasis; Alzheimer's disease; transplant rejection; stroke; antidiabetic agents; glomerulonephritis; anticancer agents
10/30/2008US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
10/30/2008US20080269193 Inhibition of heat shock protein diseases; antiproliferative agents; antiarthritic agents; antiinflammatory agents; autoimmune diseases; stroke; antiischemic agents; cardiovascular disorders; antitumor agents; anticancer agenst
10/30/2008US20080269190 Chronic obstructive pulmonary disease; asthma
10/30/2008DE102008017025A1 Pyridin-Verbingungen für flüssigkristalline Mischungen Pyridine-Verbingungen for liquid crystalline mixtures
10/30/2008CA2685141A1 New compounds 806
10/30/2008CA2684644A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008CA2684240A1 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008CA2683512A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
10/30/2008CA2682506A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008CA2681779A1 Heterocyclic hydrazide compound and pesticidal use of the same
10/29/2008EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols
10/29/2008EP1984351A1 Compounds having 5-ht6 receptor affinity
10/29/2008EP1984350A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
10/29/2008EP1984343A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
10/29/2008EP1984338A2 Pyridylphenyl compounds for inflammation and immune-related uses
10/29/2008EP1984334A2 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
10/29/2008EP1984331A1 Pyrrolidine derivatives as erk inhibitors
10/29/2008EP1983986A2 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1891038B1 Substituted n-arylpyrrolidines as selective androgen receptor modulators
10/29/2008EP1751105B1 Piperazine derivatives of alkyl oxindoles
10/29/2008EP1727798B1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
10/29/2008EP1668001B1 Substituted heteroaryl benzofuran acids
10/29/2008EP1641758B1 Diphenylpyridine derivatives, preparation and therapeutic application thereof
10/29/2008EP1556055B1 Cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure and their use in therapy
10/29/2008EP1531811B1 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
10/29/2008EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
10/29/2008CN101296925A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101296911A Arylurea derivatives as modulators of chemokine receptor activity
10/29/2008CN101296909A Pyrazine derivatives and use as pI3K inhibitors
10/29/2008CN101296903A Novel indole-containing beta agonists, method for producing them and their use as drugs
10/29/2008CN101296731A Novel benzopyran derivatives as potassium channel openers
10/29/2008CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/28/2008USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent
10/28/2008US7442813 Process for producing dioxolane nucleoside analogues
10/28/2008US7442806 Processes for preparing darifenacin hydrobromide
10/28/2008US7442713 2-thio-substituted imidazole derivatives and their use in pharmaceutics
10/28/2008US7442712 Constrained himbacine analogs as thrombin receptor antagonists
10/28/2008US7442711 Amelioration of the development of cataracts and other ophthalmic diseases
10/28/2008US7442704 Amide derivatives
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442701 Amino-heterocycles as VR-1 antagonists for treating pain
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442698 Substituted heterocyclic compounds and methods of use
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008CA2417652C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2355857C 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
10/28/2008CA2331141C Water soluble azoles as broad-spectrum antifungals
10/28/2008CA2283507C Process for preparing pyrazole derivatives
10/28/2008CA2262791C Amino acid ester containing azole antifungals
10/23/2008WO2008126918A1 Twelve-membered cyclomacrolactam derivative
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126899A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/23/2008WO2008126898A1 (aza)indole derivative and use thereof for medical purposes
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126106A2 Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008WO2008125210A1 Quinoline and naphthalene derivatives, processes for their preparation and their use in treatment of inflammatory diseases
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008096127A3 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators
10/23/2008US20080262246 Novel chemical intermediates; reacting with organometallic compound
10/23/2008US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide
10/23/2008US20080262067 pharmaceutical composition comprising idazoxan or derivatives and their therapeutically acceptable salts, racemates, optically active isomers and polymorphs.
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 694